JONATHAN SPORN net worth

Who is JONATHAN SPORN?

Jonathan Sporn is a founder of Gilgamesh Pharmaceuticals, which was part of the Y Combinator startup accelerator in Summer 2020.

Highlights:

• Y Combinator S20
• Gilgamesh Pharmaceuticals

About Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

FAQ: JONATHAN SPORN net worth and Gilgamesh Pharmaceuticals valuation

What is JONATHAN SPORN's net worth?

JONATHAN SPORN's estimated net worth is $56.0M (range $39.2M – $84.0M) as of 2026. JONATHAN SPORN is Founder at Gilgamesh Pharmaceuticals. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Gilgamesh Pharmaceuticals valuation?

Gilgamesh Pharmaceuticals's estimated valuation on Entrepreneurial Check is $600.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is JONATHAN SPORN's role?

JONATHAN SPORN is Founder at Gilgamesh Pharmaceuticals, a Y Combinator-backed startup (batch S20).